Expect AUM momentum and NIM pressure — a tale of scale vs cost-of-funds
Q1's 160% profit jump masks a deeper shift: cost-of-funds is rising as IIFL raises ₹750+ Cr in NCDs. Watch whether growth in lending AUM can outpace margin compression in the quarter ending Sept 2026.
The Setup
IIFL Finance enters Q2 riding a strong Q1 — ₹713 Cr PAT, up 160% YoY, on the back of AUM growth and NIM expansion. But the quarter presents a classic NBFC trade-off: growth is accelerating (AUM +38% YoY to ₹1.15 lakh Cr), yet the cost of funding is rising sharply. Between early September and October 5, IIFL issued ₹750+ Cr in secured and unsecured NCDs across six tranches — a refinancing push that will compress Q2 net interest margin relative to Q1's exceptional levels. The question: can lending growth and asset quality hold the line on profitability?
~₹3,400–3,500 Cr
vs ₹3,305 Cr in Q2 FY26 (YoY base); Q1 FY27 run-rate ~₹3,350 Cr
~₹500–550 Cr
vs ₹418 Cr in Q2 FY26; below Q1's ₹713 Cr but reflecting higher cost of funds
~₹1.17–1.20 lakh Cr
on-plan from ₹1.15L Cr (Q1); +40%+ YoY trajectory intact if lending grows
Likely compressed
Q1's strong NIM offset by ₹750 Cr in fresh debt costs hitting the quarter
A strong quarter would show: (i) revenue in the ₹3,500+ Cr range (reflecting steady AUM disbursals and fees); (ii) profit holding above ₹550 Cr despite margin headwinds, thanks to contained credit costs; and (iii) AUM crossing ₹1.18L Cr with no deterioration in asset quality (NPA ratios). A weak quarter would reveal: (i) revenue disappointing below ₹3,350 Cr (slowing loan growth or higher prepayments); (ii) profit sinking below ₹480 Cr (margin squeeze worse than embedded in guidance); or (iii) any uptick in Stage 2 / NPA ratios, signalling stress in the portfolio.
On Track?
IIFL remains on a strong full-year trajectory. Q1's 160% PAT growth was an outlier — driven by strong AUM momentum and exceptional NIM — but the company has guided for balanced growth through FY27. The September result should confirm that AUM growth is sustainable at 35%+ YoY and that, despite rising cost of debt, the NBFC is maintaining operating leverage. One headwind: analyst consensus has recently downgraded full-year FY27 revenue expectations (now ₹9.57k Cr, -18.6% vs prior year growth forecasts), suggesting the Street is pricing in either slower lending or competitive pressure. The Q2 result will either validate or challenge this revised outlook.
What the Street Says
Since Last Quarter
Jul 22
Q1 FY27 result: PAT ₹713.1 Cr (+160% YoY), AUM ₹1.15L Cr (+38% YoY)
Strong baseline; sets high bar for Q2
Aug 25
IIFL Home Finance tax demand: ₹963.39 Cr for FY22–23; stay granted
Subsidiary risk, not consolidated profit impact yet, but monitoring required
Sep 2–Oct 5
Six NCD issuances: ₹350 Cr + ₹130 Cr + ₹100 Cr + ₹95 Cr + ₹46.5 Cr + ₹25 Cr
Aggressive refinancing; raises blended cost of funds for Q2
Sep 5
Independent director Ramakrishnan Subramanian steps down
Routine governance; no material impact
Sep 9
Fairfax exit denial (re: IDBI Bank bid rumour)
Clarification on promoter stability; reduces M&A uncertainty
Sep 11
Two key resignations: Head of Legal (Binay Mishra), Business Head–LAP (Vinay Agarwal)
Management turnover; monitor for operational continuity
Sep 30
CTO appointed (Anubhav Rajput); Gaurav Sharma resigns
Tech leadership transition; strategic for digital lending roadmap
Oct 7
Trading window closed ahead of result announcement on Oct 15
Expected pre-result governance
Capital raising dominates the narrative. IIFL has raised ₹746.5 Cr in NCDs over five weeks — one of the fastest refinancing pushes in recent quarters — signalling confidence in growth but also suggesting the cost of wholesale funding has tightened. This will be Q2's margin story.
Ownership has shifted: FII holdings have compressed from 28.16% (Q4 FY26) to 23.86% (Q1 FY27), a 4.3pp decline. The most recent bulk/block deals (Sep 2026) show foreign fund participation (Smallcap World Fund Inc, American Funds) at ₹590, suggesting institutional appetite remains but at lower valuations. Promoter stake stable at 24.85%.
What to Watch on Result Day
1 · AUM growth rate and loan disbursals
Confirm whether the +38% YoY AUM growth is sustainable. Any sequential slowdown (Q1 to Q2) would signal either market headwinds or IIFL scaling back lending. Target: AUM >₹1.17L Cr, disbursals trending at or above Q1 run-rate.
2 · Net interest margin (NIM) and cost of funds
The critical number. Will management quantify the NCD issuances' impact on blended cost? Expect NIM to compress vs. Q1's exceptional level, but by how much? A drop >20bp would warrant scrutiny; <10bp is manageable. Management commentary on forward refinancing plans will drive sentiment.
3 · Asset quality: Stage 2 and GNPA ratios
Any deterioration in asset quality (Stage 2 uptick, GNPA >1%) would offset growth optionality. Q2 is typically a seasonal test quarter. Keep slippage < 0.5% of portfolio.
4 · IIFL Home Finance subsidiary: tax dispute update
The ₹963 Cr tax demand for FY22–23 (stay granted) will not hit Q2 P&L, but any signalling on appeal status or second-order subsidiary health matters for FY27 full-year risk.
5 · FY27 guidance and management commentary on cost pressures
Will IIFL reaffirm full-year AUM and ROA targets? Recent analyst downgrades suggest the Street is pricing in either slower growth or margin compression. Any upside surprise here would re-rate the stock.
IIFL Finance's Q2 result arrives at an inflection: strong AUM growth and a run-rate profit of ₹550+ Cr is achievable, but the cost-of-funds story is shifting. The ₹750 Cr in debt issuances were necessary to fund lending growth, but they compress the blended cost profile going into the quarter. The Street is bullish (Buy consensus, ₹740 median target), but recent EPS downgrades reflect caution on margin sustainability. Q2 will clarify whether IIFL can grow profitably despite wholesale cost headwinds — and whether the current 27% upside embedded in the consensus is justified or priced for perfection.
The three keys to watch: (1) AUM growth rate and asset quality — is the lending book still sound at current pace? (2) NIM compression quantified and forward guidance on refinancing — how much margin pain is priced in? (3) FY27 guidance reaffirmed or revised — do analyst consensus downgrades reflect macro reality or over-caution? A strong result on all three would re-rate the stock toward consensus targets.